Neurocrine Biosciences
NBIX
#1366
Rank
$15.50 B
Marketcap
$155.51
Share price
0.84%
Change (1 day)
23.01%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2025 (TTM): $0.58 Billion USD

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are $2.68 Billion USD. In 2024 the company made an earning of $0.61 Billion USD, an increase over its 2023 earnings that were of $0.31 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $0.58 B-4.8%
2024 $0.61 B96.41%
2023 $0.31 B41.13%
2022 $0.22 B73.74%
2021 $0.12 B-8.82%
2020 $0.13 B77.78%
2019 $78.46 M49.83%
2018 $52.37 M-142.57%
2017 -$0.13 Billion-14.73%
2016 -$0.15 Billion53.15%
2015 -$94.21 Million46.25%
2014 -$64.42 Million29.66%
2013 -$49.68 Million-3530.8%
2012 $1.44 M-95.73%
2011 $33.92 M
2009 -$47.69 Million-45.38%
2008 -$87.3 Million-58.87%
2007 -$0.22 Billion87.3%
2006 -$0.12 Billion351.97%
2005 -$25.08 Million-52.09%
2004 -$52.34 Million-10.98%
2003 -$58.79 Million
2001 -$43.89 Million
1999 -$19.79 Million108.32%
1998 -$9.5 Million
1996 $2.9 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
$26.14 M-95.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
$1.58 B 171.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
-$17.3 Million-102.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$22.50 B 3,758.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$1.66 B 184.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$11.85 B 1,932.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$50.55 M-91.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$41.77 Million-107.16%๐Ÿ‡บ๐Ÿ‡ธ USA